Treace Medical Concepts, Inc. (TMCI) Profit Margins
Over the twelve months to 2026-06-30, Treace Medical Concepts, Inc. (TMCI) had gross margin 79.5%, operating margin -26.2%, net margin -29.0%, free cash flow margin -12.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TMCITreace Medical Concepts, Inc.Follow TMCI — free
—
Price chart with a free account
- Market cap
- 277.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 82.1% | 82.0% | 81.2% | 80.4% | 79.8% | 79.5% | |
| Operating margin | -17.5% | -24.6% | -27.5% | -26.6% | -25.5% | -26.2% | |
| Net margin | -21.8% | -30.2% | -26.5% | -26.6% | -27.7% | -29.0% | |
| FCF margin | -21.1% | -32.1% | -24.6% | -23.3% | -13.9% | -12.2% |
USD millions · SEC XBRL
Treace Medical Concepts, Inc. — questions
- What is Treace Medical Concepts, Inc.'s gross margin?
- 79.5% over the twelve months to 2026-06-30.
- What is Treace Medical Concepts, Inc.'s operating margin?
- -26.2% over the twelve months to 2026-06-30.
- What is Treace Medical Concepts, Inc.'s net profit margin?
- -29.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Treace Medical Concepts, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.